The reimbursement for medicines is expected to decrease by SEK 185 million in 2020

26 June 2020 - Pharmaceutical companies will pay SEK 2.9 billion in reimbursement for medicines covered by side agreements between ...

Read more →

Parallel distributed or parallel imported Maviret and Viekirax remain in high cost protection

28 October 2019 - TLV has reconsidered the subsidy for parallel distributed or parallel imported Maviret and Viekirax and decided ...

Read more →